Advertisement

PharmacoEconomics & Outcomes News

, Volume 844, Issue 1, pp 5–5 | Cite as

Assessing value of emicizumab in haemophilia A with inhibitors

Clinical study
  • 2 Downloads

Reference

  1. Cortesi PA, et al. Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors. Thrombosis and Haemostasis : 30 Dec 2019. Available from: URL: http://doi.org/10.1055/s-0039-3401822

Copyright information

© Springer International Publishing AG 2020

Personalised recommendations